Active Pharmaceutical Ingredients - Dr Reddy's
EN
Arrow
EN简ESPT日
XCEED LoginConnect Now
Active Pharmaceutical Ingredients - Dr Reddy's
EN
Arrow
EN简ESPT日
Arrow

About Abiraterone Acetate API

Product

  • Therapeutic Category Oncology

  • CAS Number

    154229-18-2

  • API Technology

    Steroids

  • Dose Form

    Tablets

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, Brazil DMF, EUDMF, Korea DMF, Russia DMF

Mechanism of Action

Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1 (17 alpha-hydroxylase/C17,20 lyase). It inhibits CYP17A1 in a selective and irreversible manner via covalent binding mechanism.

Indication

ZYTIGA is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with

  • Metastatic castration-resistant prostate cancer (CRPC).
  • Metastatic high-risk castration-sensitive prostate cancer (CSPC)

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Abiraterone Acetate
Select Regulatory Requirements
Select Purpose

Related APIs

Dasatinib (Monohydrate)

Oncology

arrow

Adagrasib

Oncology

arrow

Fruquintinib

Oncology

arrow

Tucatinib

Oncology

arrow

Ripretinib

Oncology

arrow

Cabozantinib Hydrochloride

Oncology

arrow

Cabozantinib S-Malate

Oncology

arrow

Carfilzomib

Oncology

arrow

Decitabine

Oncology

arrow

Deucravacitinib

Oncology

arrow

Eribulin Mesylate

Oncology

arrow

Lomustine

Oncology

arrow

Nilotinib Hydrochloride Monohydrate (Form B)

Oncology

arrow

Olaparib (Form A)

Oncology

arrow

Acalabrutinib

Oncology

arrow

Capivasertib

Oncology

arrow

Lenalidomide (Form A)

Oncology

arrow

Midostaurin (Amorphous and Form II)

Oncology

arrow

Lenvatinib Mesylate (Form C and MIBK Solvate)

Oncology

arrow

Enzalutamide (Crystalline & Premix)

Oncology

arrow

Gemcitabine Hydrochloride

Oncology

arrow

Abiraterone Acetate

Oncology

arrow

Apalutamide (Amorphous & Form B)

Oncology

arrow

Zoledronic Acid

Oncology

arrow

Azacitidine

Oncology

arrow

Bendamustine Hydrochloride

Oncology

arrow

Relugolix

Oncology

arrow

Bortezomib

Oncology

arrow

Cabazitaxel

Oncology

arrow

Capecitabine

Oncology

arrow

Pomalidomide

Oncology

arrow

Pemetrexed Disodium Heptahydrate

Oncology

arrow

Pazopanib

Oncology

arrow

Palbociclib

Oncology

arrow

FAQs

What drug class is ABIRATERONE ACETATE API?

  • It belongs to Anti-neoplastic drug class

What is ABIRATERONE ACETATE API used to treat?

  • It is a oncology product used to treat Metastatic castration-resistant prostate cancer (CRPC). Metastatic high-risk castration-sensitive prostate cancer (CSPC)

What are the dosage strengths available for ABIRATERONE ACETATE API ?

  • Abiraterone is available in 250 mg and 500 mg dosage forms

What are offerings of Dr. Reddy's for ABIRATERONE ACETATE API?

  • We offer polymorph Form-A for Abiraterone API

What is the process available for ordering ABIRATERONE ACETATE API?
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.